ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för norverapamil. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

36 träffar

Bibliografisk träff 2016-10-14

Mass loading and removal of pharmaceuticals and personal care products including psychoactives, antihypertensives, and antibiotics in two sewage treatment plants in southern India.

Subedi B, Balakrishna K, Joshua DI, Kannan K.

Chemosphere · journal article · DOI 10.1016/j.chemosphere.2016.10.026

Bibliografisk träff 2016-07-25

Assessment of full-scale biological nutrient removal systems upgraded with physico-chemical processes for the removal of emerging pollutants present in wastewaters from Mexico.

Estrada-Arriaga EB, Cortés-Muñoz JE, González-Herrera A, Calderón-Mólgora CG, de Lourdes Rivera-Huerta M, Ramírez-Camperos E, Montellano-Palacios L, Gelover-Santiago SL, Pérez-Castrejón S, Cardoso-Vigueros L, Martín-Domínguez A, García-Sánchez L.

Sci Total Environ · journal article · DOI 10.1016/j.scitotenv.2016.07.118

Bibliografisk träff 2015-12-07

New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.

Abate G, Ruminiski PG, Kumar M, Singh K, Hamzabegovic F, Hoft DF, Eickhoff CS, Selimovic A, Campbell M, Chibale K.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.01567-15

Bibliografisk träff 2015-08-08

Impact of inhalational exposure to ethanol fuel on the pharmacokinetics of verapamil, ibuprofen and fluoxetine as in vivo probe drugs for CYP3A, CYP2C and CYP2D in rats.

Cardoso JL, Lanchote VL, Pereira MP, Capela JM, de Moraes NV, Lepera JS.

Food Chem Toxicol · research support, non-u.s. gov't; validation study; journal article · DOI 10.1016/j.fct.2015.08.002

Bibliografisk träff 2015-02-03

PBPK modeling to unravel nonlinear pharmacokinetics of verapamil to estimate the fractional clearance for verapamil N-demethylation in the recirculating rat liver preparation.

Yang QJ, Si L, Tang H, Sveigaard HH, Chow EC, Pang KS.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.114.062265

Bibliografisk träff 2014-02-14

Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.

Adams KN, Szumowski JD, Ramakrishnan L.

J Infect Dis · research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/infdis/jiu095

Bibliografisk träff 2014-01-01

Metabolite parameters as an appropriate alternative approach for assessment of bioequivalence of two verapamil formulations.

Haeri A, Javadian B, Saadati R, Dadashzadeh S.

Iran J Pharm Res · research-article; journal article

Bibliografisk träff 2014-01-01

A pharmacokinetic drug-drug interaction model of simvastatin and verapamil in humans.

Methaneethorn J, Chamnansua M, Kaewdang N, Lohitnavy M.

Annu Int Conf IEEE Eng Med Biol Soc · research support, non-u.s. gov't; journal article · DOI 10.1109/embc.2014.6944924

Bibliografisk träff 2013-09-27

Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil.

Estudante M, Maya M, Morais JG, Soveral G, Benet LZ.

Mol Pharm · research support, non-u.s. gov't; journal article · DOI 10.1021/mp400381p

Bibliografisk träff 2013-07-31

A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.

Wang J, Xia S, Xue W, Wang D, Sai Y, Liu L, Liu X.

Eur J Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejps.2013.07.012

Bibliografisk träff 2013-05-01

Stereoselective CZE method for analysis of verapamil and norverapamil in human plasma.

Resztak M, Główka FK.

Acta Pol Pharm · journal article

Bibliografisk träff 2012-08-01

Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.

Lee YS, Yoon JN, Yoon IS, Lee MG, Kang HE.

Xenobiotica · research support, non-u.s. gov't; journal article · DOI 10.3109/00498254.2011.654001

Bibliografisk träff 2012-06-07

Enantiomeric separation of verapamil and its active metabolite, norverapamil, and simultaneous quantification in human plasma by LC-ESI-MS-MS.

Singhal P, Yadav M, Winter S, Guttikar S, Patel D, Mills M, Shrivastav PS.

J Chromatogr Sci · journal article · DOI 10.1093/chromsci/bms080

Bibliografisk träff 2010-12-06

Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.

Hu N, Xie S, Liu L, Wang X, Pan X, Chen G, Zhang L, Liu H, Liu X, Liu X, Xie L, Wang G.

Drug Metab Dispos · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.110.035642

Bibliografisk träff 2010-04-01

Effect of Huang-Lian-Jie-Du-Decoction on pharmacokinetics of verapamil in rats.

Xie SS, Hu N, Jing XY, Liu XD, Xie L, Wang GJ, Liu CH.

J Pharm Pharmacol · journal article · DOI 10.1211/jpp.62.04.0005

Bibliografisk träff 2010-02-01

Absorption barriers in the rat intestinal mucosa: 1. Application of an in situ perfusion model to simultaneously assess drug permeation and metabolism.

Mudra DR, Borchardt RT.

J Pharm Sci · journal article · DOI 10.1002/jps.21912

Bibliografisk träff 2009-10-01

Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.

Hong SP, Chang KS, Koh YY, Choi DH, Choi JS.

Arch Pharm Res · journal article · DOI 10.1007/s12272-009-2015-2

Bibliografisk träff 2009-07-01

Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats.

Choi DH, Li C, Choi JS.

Eur J Drug Metab Pharmacokinet · journal article · DOI 10.1007/bf03191168

Bibliografisk träff 2008-09-20

Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats.

Choi JS, Burm JP.

Arch Pharm Res · journal article · DOI 10.1007/s12272-001-1289-z

Bibliografisk träff 2008-01-12

Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.

Choi DH, Shin WG, Choi JS.

Eur J Clin Pharmacol · clinical trial; journal article · DOI 10.1007/s00228-007-0447-5

Bibliografisk träff 2007-10-05

Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry.

Mateus FH, Lepera JS, Marques MP, Boralli VB, Lanchote VL.

J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jpba.2007.09.021

Bibliografisk träff 2006-10-01

The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.

Dadashzadeh S, Javadian B, Sadeghian S.

Biopharm Drug Dispos · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1002/bdd.512

Bibliografisk träff 2005-10-01

Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.

Kim HJ, Choi JS.

Biopharm Drug Dispos · journal article · DOI 10.1002/bdd.459

Bibliografisk träff 2005-04-01

Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.

Choi JS, Burm JP.

Arch Pharm Res · journal article · DOI 10.1007/bf02977680

Bibliografisk träff 2004-12-01

The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits.

Choi JS, Han HK.

J Pharm Pharmacol · comparative study; journal article · DOI 10.1211/0022357044814

Bibliografisk träff 2002-05-01

Pharmacokinetics of verapamil and its metabolite norverapamil from a buccal drug formulation.

Sawicki W, Janicki S.

Int J Pharm · comparative study; clinical trial; journal article · DOI 10.1016/s0378-5173(02)00069-8

Bibliografisk träff 2002-01-01

Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans.

Sawicki W.

Eur J Pharm Biopharm · comparative study; journal article · DOI 10.1016/s0939-6411(01)00189-8

Bibliografisk träff 2001-07-01

Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.

Mori Y, Hanada K, Mori T, Tsukahara Y, Hashiguchi M, Ogata H.

Biol Pharm Bull · journal article · DOI 10.1248/bpb.24.806

Bibliografisk träff 2001-06-01

A validated method for the determination of verapamil and norverapamil in human plasma.

Sawicki W.

J Pharm Biomed Anal · journal article · DOI 10.1016/s0731-7085(00)00585-9

Bibliografisk träff 1999-10-01

Enantiometric separation of verapamil and norverapamil using Chiral-AGP as the stationary phase.

Sandström R, Lennernäs H, Ohlén K, Karlsson A.

J Pharm Biomed Anal · journal article · DOI 10.1016/s0731-7085(99)00093-x